Amisulpride, a dopamine D2/D3-antagonist, prevents chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic cisplatin or anthracycline-cyclophosphamide regimens: A randomised, double-blind, placebo-controlled, dose-ranging trial

被引：0
|
作者：
Herrstedt, J. [1 ]
Summers, Y. [2 ]
Jordan, K. [3 ]
Von Pawel, J. [4 ]
Jakobsen, A. H. [5 ]
Ewertz, M. [1 ]
Chan, S. [6 ]
Naik, J. [7 ]
Karthaus, M. [8 ]
Dubey, S. [9 ]
Davis, R. [10 ]
Fox, G. [11 ]
机构：
[1] Odense Univ Hosp, Oncol, DK-5000 Odense, Denmark
[2] Univ S Manchester Hosp, Pulm Oncol Unit, Manchester M20 8LR, Lancs, England
[3] Univ Klinikum Halle Saale, Dept Oncol Haematol, Halle An Der Saale, Germany
[4] Asklepios Fachkliniken, Klin Pneumol, Munich, Germany
[5] Herlev Hosp, Dept Oncol, Copenhagen, Denmark
[6] Univ Nottingham Hosp, Acad Unit Oncol, Nottingham NG7 2UH, England
[7] Mid Yorkshire NHS Trust, Oncol, Wakefield, England
[8] Klinikum Neuperlach, Klin Hamatol Onkol & Palliativmed, Munich, Germany
[9] Derriford Hosp, Dept Oncol, Plymouth PL6 8DH, Devon, England
[10] Wexham Pk Hosp, Canc Clin Trials Off, Slough SL2 4HL, Berks, England
[11] Acacia Pharma Ltd, Clin Dev, Cambridge, England
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30662-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1573
引用
收藏
页码：S228 / S229
页数：2
相关论文
共 44 条
  • [21] Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
    Hideaki Yahata
    Hiroaki Kobayashi
    Kenzo Sonoda
    Mototsugu Shimokawa
    Tatsuhiro Ohgami
    Toshiaki Saito
    Shinji Ogawa
    Kunihiro Sakai
    Akimasa Ichinoe
    Yousuke Ueoka
    Yasuyuki Hasuo
    Makoto Nishida
    Satohiro Masuda
    Kiyoko Kato
    International Journal of Clinical Oncology, 2016, 21 : 491 - 497
  • [22] Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
    Yahata, Hideaki
    Kobayashi, Hiroaki
    Sonoda, Kenzo
    Shimokawa, Mototsugu
    Ohgami, Tatsuhiro
    Saito, Toshiaki
    Ogawa, Shinji
    Sakai, Kunihiro
    Ichinoe, Akimasa
    Ueoka, Yousuke
    Hasuo, Yasuyuki
    Nishida, Makoto
    Masuda, Satohiro
    Kato, Kiyoko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) : 491 - 497
  • [23] The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - The Aprepitant Protocol 052 Study Group
    Hesketh, PJ
    Grunberg, SM
    Gralla, RJ
    Warr, DG
    Roila, F
    De Wit, R
    Chawla, SP
    Carides, AD
    Ianus, J
    Elmer, ME
    Evans, JK
    Beck, K
    Reines, S
    Horgan, KJ
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4112 - 4119
  • [24] Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial
    Zhihuang Hu
    Ying Cheng
    Hongyu Zhang
    Caicun Zhou
    Baohui Han
    Yiping Zhang
    Cheng Huang
    Jianhua Chang
    Xiangqun Song
    Jun Liang
    Houjie Liang
    Chunxue Bai
    Shiying Yu
    Jia Chen
    Jie Wang
    Hongming Pan
    Denesh K. Chitkara
    Darcy A. Hille
    Li Zhang
    Supportive Care in Cancer, 2014, 22 : 979 - 987
  • [25] Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial
    Hu, Zhihuang
    Cheng, Ying
    Zhang, Hongyu
    Zhou, Caicun
    Han, Baohui
    Zhang, Yiping
    Huang, Cheng
    Chang, Jianhua
    Song, Xiangqun
    Liang, Jun
    Liang, Houjie
    Bai, Chunxue
    Yu, Shiying
    Chen, Jia
    Wang, Jie
    Pan, Hongming
    Chitkara, Denesh K.
    Hille, Darcy A.
    Zhang, Li
    SUPPORTIVE CARE IN CANCER, 2014, 22 (04) : 979 - 987
  • [26] Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study
    Thamlikitkul, Lucksamon
    Srimuninnimit, Vichien
    Akewanlop, Charuwan
    Ithimakin, Suthinee
    Techawathanawanna, Sirisopa
    Korphaisarn, Krittiya
    Chantharasamee, Jomjit
    Danchaivijitr, Pongwut
    Soparattanapaisarn, Nopadol
    SUPPORTIVE CARE IN CANCER, 2017, 25 (02) : 459 - 464
  • [27] A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide
    Tienchaiananda, Piyawan
    Nipondhkit, Wipada
    Maneenil, Kunlatida
    Sa-nguansai, Sunatee
    Payapwattanawong, Songwit
    Laohavinij, Sudsawat
    Maneechavakajorn, Jedzada
    ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (04) : 372 - 380
  • [28] Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy
    Suthinee Ithimakin
    Pathra Theeratrakul
    Apirom Laocharoenkiat
    Akarin Nimmannit
    Charuwan Akewanlop
    Nopadol Soparattanapaisarn
    Sirisopa Techawattanawanna
    Krittiya Korphaisarn
    Pongwut Danchaivijitr
    Supportive Care in Cancer, 2020, 28 : 5335 - 5342
  • [29] Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy
    Ithimakin, Suthinee
    Theeratrakul, Pathra
    Laocharoenkiat, Apirom
    Nimmannit, Akarin
    Akewanlop, Charuwan
    Soparattanapaisarn, Nopadol
    Techawattanawanna, Sirisopa
    Korphaisarn, Krittiya
    Danchaivijitr, Pongwut
    SUPPORTIVE CARE IN CANCER, 2020, 28 (11) : 5335 - 5342
  • [30] Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials
    Rapoport, Bernardo L.
    Chasen, Martin R.
    Gridelli, Cesare
    Urban, Laszlo
    Modiano, Manuel R.
    Schnadig, Ian D.
    Poma, Allen
    Arora, Sujata
    Kansra, Vikram
    Schwartzberg, Lee S.
    Navari, Rudolph M.
    LANCET ONCOLOGY, 2015, 16 (09): : 1079 - 1089
12345